Dendritic cell-targeting polymer nanoparticle-based immunotherapy for cancer: A review

被引:6
作者
Hu, Yeye [1 ,4 ]
Zhang, Wei [2 ]
Chu, Xiaozhong [3 ]
Wang, Aoran [3 ]
He, Ziliang [2 ]
Si, Chuan-Ling [4 ]
Hu, Weicheng [1 ,5 ,6 ]
机构
[1] Yangzhou Univ, Inst Translat Med, Sch Med, Yangzhou 225009, Peoples R China
[2] Huaiyin Normal Univ, Sch Life Sci, Huaian 223300, Peoples R China
[3] Huaiyin Normal Univ, Sch Chem & Chem Engn, Huaian 223300, Peoples R China
[4] Tianjin Univ Sci & Technol, Tianjin Key Lab Pulp & Paper, Tianjin 300457, Peoples R China
[5] Yangzhou Univ, Affiliated Hosp, Yangzhou 225009, Peoples R China
[6] Yangzhou Univ, Sch Med, Jiangsu Key Lab Expt & Translat Noncoding RNA Res, Yangzhou 225009, Peoples R China
关键词
Dendritic cell; Polymer; Target; Receptor; Immunity; POLY(GAMMA-GLUTAMIC ACID) NANOPARTICLES; ANTITUMOR IMMUNE-RESPONSES; DC-SIGN; ANTIGEN PRESENTATION; CROSS-PRESENTATION; LIPID NANOPARTICLES; RECEPTOR ENGAGEMENT; EFFICIENT DELIVERY; VACCINE DELIVERY; FC-RECEPTOR;
D O I
10.1016/j.ijpharm.2023.122703
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cancer immunity is dependent on dynamic interactions between T cells and dendritic cells (DCs). Polymer-based nanoparticles target DC receptors to improve anticancer immune responses. In this paper, DC surface receptors and their specific coupling natural ligands and antibodies are reviewed and compared. Moreover, reaction mechanisms are described, and the synergistic effects of immune adjuvants are demonstrated. Also, extracellular-targeting antigen-delivery strategies and intracellular stimulus responses are reviewed to promote the rational design of polymer delivery systems.
引用
收藏
页数:21
相关论文
共 50 条
  • [21] Nanoparticle-based cisplatin therapy for cancer
    Babu, Anish
    Amreddy, Narsireddy
    Ramesh, Rajagopal
    THERAPEUTIC DELIVERY, 2015, 6 (02) : 115 - 119
  • [22] Recent Advances in Nanotechnology for Dendritic Cell-Based Immunotherapy
    Qian, Chen
    Yang, Li-Jun
    Cui, Hong
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [23] A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy
    Yan, Zhongyi
    Wu, Yahong
    Du, Jiangfeng
    Li, Guodong
    Wang, Shengdian
    Cao, Wenpeng
    Zhou, Xiuman
    Wu, Chunjing
    Zhang, Dan
    Jing, Xueli
    Li, Yifan
    Wang, Hongfei
    Gao, Yanfeng
    Qi, Yuanming
    ONCOTARGET, 2016, 7 (26) : 40437 - 40450
  • [24] Dendritic cell vaccine immunotherapy of cancer targeting MUC1 mucin
    Kontani, K
    Taguchi, O
    Ozaki, Y
    Hanaoka, J
    Sawai, S
    Inoue, S
    Abe, H
    Hanasawa, K
    Fujino, S
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 12 (04) : 493 - 502
  • [25] Targeting dendritic cells in lymph node with an antigen peptide-based nanovaccine for cancer immunotherapy
    Qian, Yuan
    Jin, Honglin
    Qiao, Sha
    Dai, Yanfeng
    Huang, Chuan
    Lu, Lisen
    Luo, Qingming
    Zhang, Zhihong
    BIOMATERIALS, 2016, 98 : 171 - 183
  • [26] Virological and Preclinical Characterization of a Dendritic Cell Targeting, Integration-deficient Lentiviral Vector for Cancer Immunotherapy
    Odegard, Jared M.
    Kelley-Clarke, Brenna
    Tareen, Semih U.
    Campbell, David J.
    Flynn, Patrick A.
    Nicolai, Christopher J.
    Slough, Megan M.
    Vin, Chintan D.
    McGowan, Patrick J.
    Nelson, Lisa T.
    ter Meulen, Jan
    Dubensky, Thomas W., Jr.
    Robbins, Scott H.
    JOURNAL OF IMMUNOTHERAPY, 2015, 38 (02) : 41 - 53
  • [27] Nanoparticle-based drug delivery to the vagina: A review
    Ensign, Laura M.
    Cone, Richard
    Hanes, Justin
    JOURNAL OF CONTROLLED RELEASE, 2014, 190 : 500 - 514
  • [28] Engineering dendritic cell vaccines to improve cancer immunotherapy
    Perez, Caleb R.
    De Palma, Michele
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [29] Trial watch: dendritic cell vaccination for cancer immunotherapy
    Sprooten, Jenny
    Ceusters, Jolien
    Coosemans, An
    Agostinis, Patrizia
    De Vleeschouwer, Steven
    Zitvogel, Laurence
    Kroemer, Guido
    Galluzzi, Lorenzo
    Garg, Abhishek D.
    ONCOIMMUNOLOGY, 2019, 8 (11):
  • [30] Nanomedicine for improvement of dendritic cell-based cancer immunotherapy
    Hashemi, Vida
    Farhadi, Shohreh
    Chaleshtari, Mitra Ghasemi
    Seashore-Ludlow, Brinton
    Masjedi, Ali
    Hojjat-Farsangi, Mohammad
    Namdar, Afshin
    Ajjoolabady, Amir
    Mohammadi, Hamed
    Ghalamfarsa, Ghasem
    Jadidi-Niaragh, Farhad
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 83